2026-09-14T13:17:22Zhttps://gredos.usal.es/oai/requestoai:gredos.usal.es:10366/1360912025-04-30T21:15:05Zcom_10366_133436com_10366_127837com_10366_4666com_10366_3823col_10366_135874
Gestión del Repositorio Documental de la Universidad de Salamanca
author
Hernández Guio, Ana
author
Zarzuelo Castañeda, Aránzazu
author
Sánchez Martín, Almudena
2018-01-12T09:41:22Z
2018-01-12T09:41:22Z
FarmaJournal, 2 (2017)
2445-1355
http://hdl.handle.net/10366/136091
[EN]Skin lesions decrease the quality of life of cancer patients, mood, adherence and tolerance to treatment, being necessary sometimes reduce the dose or even disrupt drug therapy. The objective is to describe and estimate the incidence of cutaneous adverse effects in patients treated with oral antineoplastic, and design and implement an oncology pharmaceutical care program to prevent and manage this cutaneous toxicity. 5 months retrospective descriptive study of patients treated with oral antineoplastic in a university hospital in Spain, evaluation of results of previous descriptive study and design pharmaceutical care program (interviews and algorithm) and preparing of educational materials (brochures). Of 549 patients, 131 (23.86%) had cutaneous adverse effects, mainly hand-foot syndrome (35.96%). Of 25 drugs analyzed, 21 were related with effects, highlighting the incidence with axitinib (100%). There is a high incidence of cutaneous adverse effects in patients treated with oral antineoplastic, which could decrease their quality of life and even disrupt drug therapy. It is therefore necessary to develop pharmaceutical care programs to inform, educate and support to cancer patients about these adverse effects.
spa
Attribution-NonCommercial-NoDerivs 3.0 Unported
Efectos adversos dermatológicos
Cuidados de la piel
Cáncer
Tratamiento oncológico
Cutaneous side effects
Skin care
Cancer
Cancer treatment
Cuidados de la piel tras el tratamiento oncológico
info:eu-repo/semantics/article
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
URL
https://gredos.usal.es/bitstream/10366/136091/1/Cuidados_de_la_piel_tras_el_tratamiento_.pdf
File
MD5
5ed25e1a098d0f8303275966bff318ed
199095
application/pdf
Cuidados_de_la_piel_tras_el_tratamiento_.pdf
URL
https://gredos.usal.es/bitstream/10366/136091/4/Cuidados_de_la_piel_tras_el_tratamiento_.pdf.txt
File
MD5
29d4c5a64b814f5b61c593d73612153e
26753
text/plain
Cuidados_de_la_piel_tras_el_tratamiento_.pdf.txt